Quantifying the waning of humoral immunity

Area of Science:

• Immunology
• Vaccinology
• Mathematical Biology

Background:

• Immunological memory is crucial for long-term protection against pathogens.
• Quantifying antibody titer decline over time remains a challenge due to the long duration of studies required.
• Existing models for antibody waning lack consensus and may underestimate protective immunity duration.

Purpose of the Study:

• To identify the most accurate mathematical model for describing antibody titer waning over time.
• To re-evaluate the duration of protective antibody levels following infection or vaccination.
• To explore methods for predicting long-term antibody waning from shorter-term data.

Main Methods:

• Analysis of the largest available dataset on antibody titers post-immunization.
• Comparison of a power-law model against other frequently used models for antibody waning.
• Statistical evaluation of model fit and predictive accuracy.

Main Results:

• A power-law model demonstrated a superior fit for describing antibody titer waning compared to other models.
• Protective antibody levels for many vaccine and virus antigens may persist longer than previously estimated.
• Antibody waning rates for protein toxoid vaccines, like tetanus, appear comparable to those from live virus infections.

Conclusions:

• The power-law model provides a more accurate quantitative description of antibody waning.
• Long-term antibody persistence may be underestimated by current models.
• Short-term data (1-3 years) can be used with the power-law model to rapidly estimate long-term antibody waning for new vaccines, improving immunity assessment.